Autoantibodies to cardiac troponin in acute coronary syndromes

Clinica Chimica Acta

Volumn 411, Issue 21-22, 2010, Pages 1793-1798

  Lindahl, Bertil ^a   Venge, Per ^a   Eggers, Kai M ^a   Gedeborg, Rolf ^a   Ristiniemi, Noora ^b   Wittfooth, Saara ^b   Pettersson, Kim ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

Antibodies; Diagnosis; Myocardial infarction; Prognosis; Troponin I

Indexed keywords

AUTOANTIBODY; TROPONIN I;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ACUTE CORONARY SYNDROME; AGED; AUTOANTIBODIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; TROPONIN I;

EID: 77956464892     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.08.005     Document Type: Article

References (22)

1. Thygesen K., Alpert J.S., White H.D. On behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal Definition of Myocardial Infarction. Circulation 2007, 116:2634-2653.
2. Ottani F., Galvani M., Nicolini F.A., et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000, 140:917-927.
3. Becattini C., Vedovati M.C., Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007, 116:427-433.
4. Latini R., Masson S., Anand I.S., et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007, 116:1242-1249.
5. Eggers K.M., Lagerqvist B., Venge P., Wallentin L., Lindahl B. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality. Circulation 2007, 116:1907-1914.
6. Wu T.-T., Yuan A., Chen C.-Y., et al. Cardiac troponin I levels are a risk factor for mortality and multiple organ failure in noncardiac critically ill patients and have an additive effect to the apache II score in outcome prediction. Shock 2004, 22:95-101.
7. Zethelius B., Johnston N., Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 2006, 113:1071-1078.
8. Reichlin T., Hochholzer W., Bassetti S., et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009, 361:858-867.
9. Venge P., Johnston N., Lindahl B., James S. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia. J Am Coll Cardiol 2009, 54:1165-1172.
10. Eriksson S., Junikka M., Laitinen P., Majamaa-Voltti K., Alfthan H., Pettersson K. Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component. Clin Chem 2003, 49:1095-1104.
11. Eriksson S., Halenius H., Pulkki K., Hellman J., Pettersson K. Negative interference in cardiac troponin I immunoassays by circulating troponin autoantibodies. Clin Chem 2005, 51:839-847.
12. Eriksson S.V., Hellman J., Pettersson K. Autoantibodies against cardiac troponins. N Engl J Med 2005, 352:98-100.
13. Eriksson S., Junikka M., Pettersson K. An interfering component in cardiac troponin I immunoassays-its nature and inhibiting effect on the binding of antibodies against different epitopes. Clin Biochem 2004, 37:472-480.
14. Pettersson K., Eriksson S., Wittfooth S., Engstrom E., Nieminen M., Sinisalo J. Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients. Clin Chem 2009, 55:938-945.
15. Lagerqvist B., Husted S., Kontny F., Ståhle E., Swahn E., Wallentin L. 5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study. Lancet 2006, 368:998-1004.
16. Venge P., Lindahl B., Wallentin L. New generation cardiac troponin I assay for the access immunoassay system. Clin Chem 2001, 47:959-961.
17. Eggers K.M., Jaffe A.S., Lind L., Venge P., Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem 2009, 55:85-92.
18. Cockcroft D., Gault M. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
19. Eggers K.M., Lagerqvist B., Oldgren J., Venge P., Wallentin L., Lindahl B. Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome. Am Heart J 2008, 156:588-594.
20. Goser S., Andrassy M., Buss S.J., et al. Cardiac troponin I but not cardiac troponin T induces severe autoimmune inflammation in the myocardium. Circulation 2006, 114:1693-1702.
21. Leuschner F., Li J., Goser S., et al. Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction. Eur Heart J 2008, 29:1949-1955.
22. Kaya Z., Goser S., Buss S.J., et al. Identification of cardiac troponin I sequence motifs leading to heart failure by induction of myocardial inflammation and fibrosis. Circulation 2008, 118:2063-2072.